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The authors demonstrate a novel, efﬁcient, and widely applicable approach to direct the patterning
of ligand-functionalized organic nanoparticles derived from albumin on nonconductive,
biodegradable polymeric substrates. In contrast to traditional deposition methods for inorganic
nanoparticles, the approach involves oxygen plasma treatment of spatially restricted regions on a
nonbiopermissive polymer. Albumin nanoparticles conjugated with a truncated fragment of
ﬁbronectin containing the Arg-Gly-Asp domain were successfully patterned and used as templates
to elicit adhesion and spreading of human mesenchymal stem cells and ﬁbroblasts. Attachment and
spreading of both cell types into the plasma-exposed polymer areas was considerably more
pronounced than with the ligand alone. The authors hypothesize that the underlying mechanism is
oxygen plasma treatment-induced selective enhancement of ligand exposure from the deposited
functionalized nanoparticles, which facilitates ligand receptor clustering at the cell membrane. The
results highlight a promising nanoscale approach to modulate ligand presentation and spatially
direct cell attachment and phenotypic behaviors. © 2010 American Vacuum Society.
DOI: 10.1116/1.3507236
I. INTRODUCTION
The arrangement of living cells is crucial for the function-
ality of tissues during development and regeneration.1,2 The
formation of functional tissues can result from optimal cell-
cell and cell-extracellular matrix contacts, which frequently
require the precise display of adhesion ligands. Extracellular
matrix geometry and cell-matrix interactions, in particular,
have been shown to play a crucial role in guiding cell fate
and control processes such as apoptosis, proliferation, and
differentiation.3–6 Therefore, considerable effort has been
dedicated to manipulate the presentation of extracellular ma-
trix ligands and proteins to spatially guide cell behavior.
One approach for spatially directing cell fate involves the
creation of cell or protein patterns. Controlling the speciﬁc
placement of cells is necessary in tissue engineering applica-
tions such as morphogenesis or networking,7 and patterned
templates could be used for basic scientiﬁc research and pro-
vide mechanistic insights into cell attachment,6 migration,8
and cell-cell or cell-extracellular matrix communications.5 It
could also lead to improvements in the development of de-
vices such as sensors,9 drug and protein screening tools,10,11
and microelectromechanical systems MEMS.12 Therefore,
techniques, such as microcontact printing,13 micromolding in
capillaries,14 dip-pen lithography,15 photolithography,16 and
electron beam lithography,17 among others, have been used
to pattern proteins,18 cells,19 and even bacteria.20
Recently, interest in nanoscale presentation of ligands and
proteins to manipulate cell function and fate has deepened;
speciﬁcally, diverse types of nanoparticles are being explored
for this application since these promote ligand presentation
at the regimen over which receptor-ligand interactions occur.
Previous research showed that presenting ligands and pep-
tides in a clustered fashion results in the subsequent cluster-
ing of integrins, cell surface receptors, and promotes cell
actions such as enhanced adhesion and motility.21 Therefore,
nanoparticles are a natural means to present ligands, pro-
teins, and peptides at the nanoscale, mimic ligand clustering,
and promote integrin clustering to trigger or augment cell
functions. For example, Cavalcanti-Adam et al.22 investi-
gated the effect of ligand spacing on cell morphology and
cytoskeletal organization by presenting Arg-Gly-Asp RGD
peptides on gold nanoparticles at varying distances, and
Mannix et al.23 demonstrated the feasibility of using mag-
netic nanoparticles to actuate integrin clustering.
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These studies have validated the use of ligand-
functionalized nanoparticles to manipulate cell behavior, but
there is a lack in the use of nanoparticles to spatially guide
cell fate. To date, nanoparticle patterning has been explored
mostly for electronic sensor and device applications, and
nanoparticles made of silver,24 gold,25 and magnetic26 mate-
rials have been successfully arranged into templates. These
recent reports, however, are limited by the materials used,
which are neither biodegradable nor amenable to bioactive
remodeling. Thus, patterning of organic nanoparticles on bio-
compatible and bioresorbable materials remains a challenge
and is the major topic for this study. Speciﬁcally, we sought
to template biodegradable albumin nanoparticles on biocom-
patible but nonpermissive tyrosine-derived polycarbonates
for spatial guidance of cells. We have previously established
that substrates adsorbed with truly nanoscale albumin-
derived carriers functionalized with cell adhesion ligands can
affect cell adhesion and motility.27 In this study, we demon-
strate a technique to establish spatially controlled patterns of
the albumin nanoparticles on nonpermissive polymer ﬁlms
by using microscale plasma-initiated patterning -PIP,
which uses oxygen gas plasma to etch polymer surfaces, to
organize cell attachment and spreading. This platform of mi-
cropatterned nanoparticle substrates greatly sensitizes cell
adhesion and morphogenesis to the presented ligands. Given
the enhanced bioactivity of such biofunctionalized particles,
such templated substrates could serve as effective model bio-
interfaces for study of cell responses to organize ligands.
II. MATERIALS AND METHODS
A. Albumin nanoparticle synthesis
Albumin nanoparticles ANPs were synthesized by dena-
turing ﬁltered 0.22 m ﬁlter, Fisher human serum albumin
30% w/v, Sigma, St. Louis, MO diluted to 1% v/v in
phosphate buffer saline PBS through an increase in pH to
10.6 by the addition of 0.1M NaOH and a subsequent slow
increase in temperature to 80 °C. The temperature was
maintained for 10 min and the solution was then rapidly
cooled to room temperature in an ice bath. After maintaining
the temperature at 25 °C for 10 min, the pH was decreased
to 5.9 using 0.1N HCl and the temperature was increased
to 37 °C slowly, without stirring. Upon reaching the tem-
perature, the solution was stirred in order to induce self-
assembly of the denatured albumin into the nanoparticles.
The solution was allowed to stir to allow for nanoparticles to
aggregate and then incubated with 0.1% w/v iodoacetamide
Sigma, St. Louis, MO at room temperature for 1 h to stop
the reaction. The nanoparticle solution was dialyzed at 4 °C
overnight molecular weight cutt-ogg MWCO 100 kDa to
remove any unreacted monomeric albumin and ﬁltered again
0.22 m ﬁlter, Fisher to remove large aggregates. Nano-
particle sizes ranged from 30 to 140 nm.
B. Fibronectin fragment production and puriﬁcation
Albumin nanoparticles were functionalized with a trun-
cated fragment of ﬁbronectin that consists of the ninth and
tenth type III domains of the protein. Fibronectin, a dimeric
glycoprotein, is involved in cellular processes such as adhe-
sion, spreading, and migration, and can help regulate tissue
processes such as wound healing.28 Both the ninth and the
tenth type III domains within the selected ﬁbronectin frag-
ment FNf associate with integrins, cell surface receptors,
and trigger intracellular signaling related to cell spreading,
growth, and migration.29–31 The FNf was produced as previ-
ously described by cloning ﬁbronectin cDNA into a pGEX
vector for expression as a glutathione-S-transferase fusion
protein.27 Escherichia coli cells were transformed with the
protein construct and fusion proteins were separated from
bacterial lysates by glutathione-sepharose afﬁnity chroma-
tography GE Healthcare, Piscataway, NJ.
C. Albumin nanoparticle functionalization
The ANPs were functionalized with the FNf protein using
bioconjugation and peptide chemistry techniques32 as de-
scribed before.27 Brieﬂy, both FNf and ANP concentrations
were measured using the BCA protein assay Pierce, Rock-
ford, IL. N-succinimidyl 3-2-pyridyldithiopropionate
SPDP Sigma, St. Louis, MO, a heterobifunctional cross-
linking agent, can react with the amine groups in the proteins
to form an amide linkage at one end, while the
2-pyridyldithiol group at the other end can react with sulfhy-
dryl residues to form a disulﬁde bond. The FNf and ANPs
were separately reacted with the SPDP for 30 min at room
temperature at a concentration of 500 M. The FNf was
then reacted with dithiothreitol DTT for 30 min at room
temperature at a concentration of 0.5 mg DTT/mg of FNf to
form a free sulfhydryl group. The reacted protein and nano-
particles were then dialyzed MWCO 6 kDa overnight at
4 °C and the ﬁnal concentration of each was again measured
by BCA protein assay. ANP-SPDP and FNf-SPDP-DTT were
then reacted together for 4–6 h at room temperature for func-
tionalization and dialyzed MWCO 100 kDa overnight at
4 °C to remove any unreacted species. The ﬁnal concentra-
tion of FNf and albumin in the FNf-ANPs was then deter-
mined using the enzyme-linked immunosorbent assay
ELISA as previously described.27,33
D. Cell culture
To test the biofunctionality of patterned nanoparticles and
their effect on cell behavior, we used nanoparticle templates
to pattern human mesenchymal stem cells and human ﬁbro-
blasts. Human mesenchymal stem cells MSCs were pur-
chased from Lonza Lonza, Basel, Switzerland. Mesenchy-
mal stem cells were harvested and cultured from normal
human bone marrow. Cells were tested for purity by ﬂow
cytometry and for their ability to differentiate into osteo-
genic, chondrogenic, and adipogenic lineages. Cells were
tested positive for CD105, CD166, CD29, and CD44, and
negative for CD14, CD34, and CD45. Different lots of MSCs
MSCs derived from various donors were used to exclude
donor-dependency. Only passages earlier than eight were
used in this study. Human mesenchymal stem cells hMSCs
were cultured with a human mesenchymal stem cell media
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kit Lonza, Basel, Switzerland. Human ﬁbroblasts were iso-
lated from neonatal foreskin and cultured in McCoy’s 5A
medium Invitrogen, Chicago, IL supplemented with 10%
fetal bovine serum, 1% Penicillin/Streptopmycin Biowhit-
taker, Walkersville, MD, and 1% L-glutamine Invitrogen,
Chicago, IL. Both cell types were supplemented with
serum-free media during and at least 16 h prior to experi-
mentation.
E. Establishment of micropatterned albumin
nanoparticles
PolyDTE-co-8% PEG1K carbonate was selected for pat-
terning studies not only because of its biocompatibility but
also because it inhibits both protein and cell attachment.34
The polymer, in powder form, was diluted in a 98.5% v/v
methylene chloride/1.5% v/v methanol solution at 1% w/v.
The solutions were then spin-coated at 4000 rpm onto acid-
cleaned glass coverslips to form thin ﬁlms 100 nm of
polymer on the glass. An elastomeric polydimethylsiloxane
PDMS stamp with parallel grooves 10–400 m in width
and 5–10 m in height and open at both ends was then
utilized to selectively expose areas of the polymer surface to
oxygen plasma, as shown in Fig. 1A. These sizes were
speciﬁcally chosen to guide cell processes, which occur at
the microscale, and conﬁrm the functionality of the nanopar-
ticles. The stamp was fabricated by pouring a Sylgard 184
silicone elastomer kit at a base weight to cross-linker weight
ratio of 10:1 over lithographically created masters.35 There-
fore, while some of the substrates are protected by the PDMS
stamp, the area under the grooves is exposed to the oxygen
plasma. The polymer was treated at 50 W for 60–120 s to
ensure sufﬁcient functionalization. After plasma treatment,
nanoparticle solutions were incubated on the polymer surface
overnight at 4 °C to ensure binding and adsorption of the
nanoparticles onto the substrate. A schematic of the resulting
nanoparticle patterns is shown in Fig. 1B.
More complex patterning was also induced by doing a
double exposure of the surface to the plasma. In this case, a
single pattern was formed by exposing the surface, with the
stamp, for 60 s at 50 W, as shown in Fig. 1C. The stamp
was then rotated by 90° and the surface was exposed to the
plasma again for 60 s at 50 W. Nanoparticle solutions were
again incubated on the polymer surface after treatment over-
night at 4 °C. Consequently, crossed patterns, as shown in
the schematic in Fig. 1C, were obtained, where selected
regions were either unexposed, exposed for 60 s single ex-
posed, or exposed for a total of 120 s double exposed.
Single and cross-patterning approaches allowed for the spa-
tial organization of biofunctional nanoparticles into simple
and more complex arrays, respectively.
F. Zeta-potential measurements of albumin
nanoparticles
The surface charge of unfunctionalized and functionalized
albumin nanoparticles was measured by dynamic light scat-
tering using Zetasizer Nano ZS Malvern, Westborough,
MA. The nanoparticles were diluted in PBS at 1:10 and
injected into the disposable folded capillary cells Malvern,
Westborough, MA by a syringe. Three measurements were
recorded at 20 s/sample at room temperature.
G. Cell patterning
To pattern human mesenchymal stem cells and ﬁbroblasts,
nanoparticle templates of sizes ranging from 1010 to
200200 m2 were prepared as described earlier and
washed. Fibroblasts were trypsinized at 37 °C for 5 min,
centrifuged at 1000 rpm for 5 min, and resuspended in
trypsin neutralizing solution Sigma, St. Louis, MO. Human
mesenchymal stem cells were trypsinized at 37 °C for 5
min, neutralized by MSC growth medium, and centrifuged at
600 g for 5 min. Cells were then counted, diluted to
10–50 000 cells /cm2, and cultured on the polyDTE-co-8%
PEG1K carbonate patterned with the biofunctional nanopar-
ticles at a FNf concentration of 2–20 g /cm2. As a control,
patterning of the ligand alone was also done. After plasma
treatment, as described above, the ligand was diluted in PBS
to the same concentration and the substrates were incubated
FIG. 1. Schematic illustrating the microscale plasma-initiated patterning process. A A PDMS stamp is placed on the biocompatible, bioresorbable polymer
surface and treated in oxygen plasma at a pressure of 660 mTorr for 60–120 s and 50 W. Areas of the polymer exposed to the plasma undergo surface
functionalization via the formation of end groups by interaction with the radicals, electrons, and ions in the oxygen plasma. B Biofunctional ANPs then
preferentially adsorb to the exposed area of the material. C By exposing the polymer to the oxygen plasma for 60 s, rotating the stamp by 90°, and exposing
the polymer to the oxygen plasma for 60 s again, areas of differentially exposed polymer enabled the differential deposition of nanoparticles for cell
attachment.
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with the solution at 4 °C overnight. Similarly, patterning
with the whole-length ﬁbronectin as a control was done for
control at a concentration of 10 g /cm2. Substrates were
then washed and cells were cultured at a cell seeding density
of 10–50 000 cells /cm2, as described above.
H. Visualization of cell adhesion on patterned ANPs
Cell seeding on the microscale patterns of the polymer-
deposited nanoparticles was assessed by ﬂuorescent labeling
of ﬁxed cells 6–24 h after seeding. For staining, cells were
washed three times with Dulbecco’s phosphate buffered sa-
line DPBS with Ca2+ and Mg2+, ﬁxed with 3.7% formalde-
hyde for 15 min at room temperature, washed, permeabilized
with 0.5% Triton X-100 in PBS for 15 min at room tempera-
ture, and washed again. Samples were then blocked with 3%
calcein obtained from fat-free, dry powdered milk, Sigma,
St. Louis, MO for 1 h and washed. For actin staining, cells
were incubated with ﬂuorescein phalloidin at a 1:200 dilu-
tion for 1 h at room temperature and washed. Finally,
Vectashield with 4 ,6-diamidino-2-phenylindole DAPI was
added to the samples for nuclear staining as well as to pre-
vent bleaching.
I. Fluorescence imaging of ANP patterns
To visualize the organization of nanoparticles into pat-
terns, ﬂuorescence microscopy was employed. Nanoparticle
solutions were ﬁrst incubated on the micropatterned sub-
strates overnight at 4 °C. Unbound nanoparticles were
washed three times with PBS. ANPs were ﬁxed in 3.7%
formaldehyde for 15 min at room temperature, washed three
times in DPBS with Ca2+ and Mg2+, blocked with 3% calcein
obtained from fat-free, dry powdered milk, Sigma, St.
Louis, MO, and washed again. Subsequently, they were in-
cubated with antialbumin primary antibody produced in
mouse Sigma, St. Louis, MO at a 1:1000 dilution overnight
at 4 °C, washed three times, and incubated with ﬂuorescein
isothiocyanate FITC-conjugated Donkey antimouse IgG at
a 1:200 dilution Jackson Immunolabs, West Grove, PA for
2 h at room temperature. The stained patterns were then
washed again and stored at 4 °C. Staining was also per-
formed with the antibodies in the absence of nanoparticles to
test for nonspeciﬁc binding of the antibodies to the micro-
patterned substrates and to ensure that the patterns observed
were a result of nanoparticle patterning and not antibody
patterning data not shown.
J. Atomic force microscopy of ANP patterns
The uniformity of nanoparticle organization was exam-
ined using atomic force microscopy AFM. Brieﬂy, ANPs
were also incubated on the micropatterned substrates at 4 °C
overnight. Unbound nanoparticles were washed three times
and kept in PBS. A Bioscope III Digital Instruments, Santa
Barbara, CA in ﬂuid contact mode was then used to image
the patterns in solution.
K. Scanning electron microscopy of ANP patterns
For scanning electron microscopy, the nanoparticle solu-
tions were incubated on the substrates overnight at 4 °C and
washed ﬁve times with distilled water to remove excess salts
that could obstruct imaging. Samples were then allowed to
dry at room temperature and sputter coated with gold-
palladium. An Amray 1830 with a LaB6 electron gun at 20
kV was employed for imaging.
L. Quantiﬁcation of exposure of FNf, adhesive
ﬁbronectin fragment
To better investigate the surface presentation of the ligand
on the patterned substrates, we measured their surface ad-
sorption via ELISA. Speciﬁcally, an ELISA using anti-GST
antibody was performed to quantify the differences in protein
binding for GST-FNIII9–10 between untreated and plasma-
treated polyDTE-co-8% PEG1K carbonate coverslips. Un-
treated and plasma-treated polyDTE-co-8% PEG1K carbon-
ate cover slips were incubated overnight at 4 °C with either
FNf-ANP or FNf at different dilutions to avoid oversaturat-
ing the substrate. Fnf standards were made by diluting stock
FNf to 20 g /ml with PBS and making 1:2 serial dilutions.
Wells were washed ﬁve times with PBS to remove unbound
ligand and incubated with blocking buffer 13% nonfat dry
milk for 1 h at 37 °C. After washing ﬁve times with PBS,
substrates were incubated with rabbit anti-GST 70 ng/ml
Sigma for 1 h at 37 °C. Wells were washed and further
reacted with an appropriate horseradish peroxidase-
conjugated goat antirabbit antibody 1:40 000 Sigma for 1
h at 37 °C. Sigma-FAST OPD tablets Sigma were used
according to manufacturer’s protocol as a substrate for the
detection of peroxidase activity. The color reaction was de-
veloped for 30 min and absorbance read at 450 nm on a
multiwell plate reader. The levels of GST-FNIII9–10 conju-
gated to ANC were obtained by linear regression utilizing
standard curve of FNf absorbances. The absorbance reading
of the GST-FNIII9–10–ANC was used to estimate the con-
centration of GST-FNIII9–10 necessary to elicit “equivalent
levels” of GST-FNIII9–10 adsorbed using linear regression
based on the standard curve of GST-FNIII9–10 absorbances.
M. Immunocytochemistry of integrin 5 1 receptors
in patterned cells
MSCs can be spatially patterned onto 100 m wide
stripes where the FNf-ANPs were speciﬁcally adsorbed due
to the discontinuous distribution of hydrophilic regions
etched by plasma treatment. In the studies on integrin local-
ization, cells were seeded in serum-free media and started to
form obvious patterns after 16 h. Serum-free medium was
chosen to avoid proteins and growth factors present in
serum-containing media and to avoid any effect these may
have to cell patterning. This ensured the isolation of the ef-
fect of the functionalized nanoparticles. The cells were ﬁxed
and permeabilized with 0.5% Triton X-100/PBS for 15 min
at RT. After blocking, the samples were incubated overnight
at 4 °C in mouse antihuman integrin 5 isotype: IgG2b, sc-
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59761, Santa Cruz, USA and antihuman integrin 1 iso-
type: IgG1, sc-13590, Santa Cruz, USA, both at 1:100 dilu-
tion. After three washes with PBS, Alexa Fluor® 488
conjugated-antimouse IgG2b and Alexa Fluor® 594
conjugated-antimouse IgG1 antibodies Invitrogen, USA
were added to visualize the antigens. Images were taken by
the Nikon ﬂuorescent microscope and Leica SP2 confocal
microscope.
III. RESULTS
A. Nanoparticle pattern characterization
Figure 2A shows the stained pattern of the nanoparticles
under ﬂuorescence microscopy. The stamp used had a
400 m stripe of exposed area by 100 m of unexposed
area; staining of the nanoparticles is observed on the
400 m stripes, indicating that nanoparticles preferentially
adsorb to the plasma-treated areas and do not adsorb onto the
untreated areas. Figure 2B demonstrates nanoparticle pat-
terning with atomic force microscopy. It is clear from the
AFM that while nanoparticles form a monolayer on plasma-
exposed regions of the polymer, they minimally adsorb to the
unexposed areas of the polymer. The patterns were further
conﬁrmed with scanning electron microscopy, shown in Figs.
2C–2E. Figure 2C shows two plasma-exposed stripes to
which the ANPs preferentially adsorbed, with the unexposed
stripes showing no nanoparticle adsorption. A higher magni-
ﬁcation image, showing the nanoparticles adsorbed on one of
the plasma-exposed stripes, is shown in Fig. 2D, with a
higher magniﬁcation image of the nanoparticles in the stripe
shown in Fig. 2E.
B. Fibroblast adhesion to micropatterned
nanoparticles
We ﬁrst chose to investigate the feasibility of nanoscale,
biologically active ANP templating by creating patterns with
primary ﬁbroblasts.
Figure 3A shows the cell adhesion responses obtained
with the patterned biofunctionalized nanoparticles when us-
ing a 4040 m2 stamp. In contrast to the patchy patterns
obtained with the ligand alone Fig. 3D, distinct patterns
covering the entire stamped area can be obtained by using
the ligand-functionalized nanoparticles. A higher magniﬁca-
tion image of the patterns obtained with the functionalized
nanoparticles shown in Fig. 3B demonstrates that cells
remained highly conﬁned to the plasma-exposed areas. Fur-
thermore, it also can be seen that cells spread along the
plasma-exposed area, in some cases even exhibiting a den-
dritic morphology. When patterning with ligand-
functionalized nanoparticles, edge effects were not observed
even when using a stamp with smaller features 10
10 m2 that induced increased cell conﬁnement, as can
be seen in Fig. 3C. In this case, the cells still spread
throughout the striped area, instead of being conﬁned to the
edges of the plasma-treated areas, as is the case with the FNf
patterns. Figure 3D shows the patterns that were obtained
when using the ligand alone. It can be easily observed that
the patterns were patchy, only forming in small areas scat-
tered throughout the sample. Most cells spread on the sub-
strate in a random, disorganized way. A higher magniﬁcation
ﬂuorescence microscopy image of the ligand-alone patterned
areas Fig. 3E shows that cells are thin and elongated, not
spread inside the plasma-treated area of 40 m. In fact, the
FIG. 2. Color Biointerfacial characterization of spatially restricted patterning of bioactive albumin nanoparticles. A Fluorescence microscopy image of
patterned nanoparticles on polyDTE-co-8% PEG1K carbonate. Brieﬂy, after plasma-initiated patterning of the substrate with 660 mTorr oxygen at 50 W for
120 s, the nanoparticles were adsorbed onto the surface at 4 °C overnight, then washed, ﬁxed, and stained with mouse antihuman serum albumin as a primary
antibody and FITC-conjugated Donkey antimouse secondary antibody for visualization under ﬂuorescence. B Atomic force microscopy image of nanopar-
ticle patterns on polyDTE-co-8% PEG1K carbonate. While nanoparticle monolayers are observed on one of the stripes the plasma-exposed area, minimal
nanoparticle adsorption is observed on the other stripes unexposed or plasma-protected areas. C Scanning electron microscopy image of the nanoparticles
patterned on the polymer substrates after plasma treatment. D High magniﬁcation scanning electron microscopy image of C. E Higher yet magniﬁcation
of plasma-treated region shows organization of nanoparticles in D.
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patterned ﬁbroblasts appear to be conﬁned to the edges of the
plasma-exposed polymer stripes, and the few patterns that
were observed with the ligand alone may have resulted from
the combination of the presence of protein and these plasma-
exposed polymer edges rather than from patterned ligand.
The optimal surface density of ANPs for both MSC and ﬁ-
broblast cell attachment ranged from 3.5 to 4 g /cm2.
The formation of more complex biological templates with
functionalized ANPs was explored by cross-patterning. Se-
rial exposure of stamped regions was achieved after rotating
the stamp onto the polymer, as described earlier and shown
in Fig. 1C. In this more complex crossed-patterning, areas
with different amounts of plasma treatment were created,
where selected zones were either shielded from the plasma
i.e., unexposed, exposed for 60 s, or exposed for 120 s. As
a result, when cell adhesion was examined, cells became
arranged into square- and rectangularlike patterns, as shown
in Fig. 4A, rather than the striped patterns shown in Figs.
3C–3E. Higher magniﬁcation imaging shown in Fig.
4B indicates that the patterned areas are comprised of ei-
ther single cells or a few cells that attached to and spread
along while staying completely conﬁned by the etched poly-
mer areas. Double pattering with the ligand alone control
was unsuccessful at eliciting more complex cell adhesion
patterns, again validating the importance of patterning with
biofunctionalized nanoparticles. As can be seen in Fig. 4C,
no cell conﬁnement and no distinct patterns can be observed
when the double-patterned substrates were incubated with
the ligand solution.
C. Human mesenchymal stem adhesion to patterned
nanoparticles
The effects of nanoparticle micropatterns were probed
next using a different cell type, hMSCs. When culturing the
FIG. 3. Color Effect of spatially patterned bioactive, albumin nanoparticles on ﬁbroblast adhesion and organization. A Fluorescence microscopy image
showing how, in the presence of ligand-functionalized albumin nanoparticles, spatial arrangement of ﬁbroblasts occurs across the 4040 m2 stamped area,
in comparison to the ligand alone, which formed patches of patterns. B Higher magniﬁcation ﬂuorescent images show that cells spread across the pattern,
adapting to the topography of the stripe. C Edge effects are not observed even by patterning using the 1010 m2 stamp with the nanoparticles, despite
the conﬁned area. D Fluorescence microscopy image of ﬁbroblasts patterned with ligand alone using a 4040 m2 stamp. Patterning was sporadic and
found only in small areas green—actin; blue—DAPI. E Higher magniﬁcation ﬂuorescence microscopy image of the ﬁbroblast patterns with ligand alone
suggests that cells elongate along the edges of the pattern rather than stretching along the entire plasma-exposed areas. Cells appear to be conﬁned to the edges
of the stripe.
FIG. 4. Color More complex cell patterns can be obtained through differential deposition of albumin nanoparticles on polymer substrates. A Fluorescence
microscopy image of ﬁbroblasts double-patterned with ligand-functionalized nanoparticles. Double patterns were induced by exposing polyDTE-co-8%
PEG1K carbonate spin-coated on glass cover slips for 60 s, then rotating the stamp by 90°, and exposing the polymer for another 60 s. BA higher resolution
ﬂuorescent image shows the cells adapting their morphology to the areas that were most exposed by plasma and appeared almost dendritic. C When using
the ligand alone, no double patterning was observed.
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hMSCs on the FNf-ANPs, well-deﬁned patterns were ob-
served Figs. 5A and 5B, with the cells conﬁned to the
plasma-exposed areas exhibiting high levels of cell spread-
ing. Figures 5C and 5D show hMSC patterning with the
ligand, ﬁbronectin fragment Fnf, alone at 4 and 20 mag-
niﬁcation. Like the ﬁbroblasts, hMSCs did not form distinct
patterned areas on ligands deposited in the absence of nano-
particles and did not spread evenly within the plasma-
exposed areas. Next, we compared effects of patterned bio-
functionalized ANPs to those on patterned whole-length
protein, ﬁbronectin. Increased degree of cell spreading was
observed when full length ﬁbronectin was adsorbed onto
plasma-treated polymer surface Figs. 5E and 5F in com-
parison to ﬁbronectin fragment alone; however, the cell or-
ganization was not as contiguous as that on ﬁbronectin frag-
ment displayed from ANPs. Thus, presentation of a small
recombinant ﬁbronectin fragment 50 kDa from patterned
nanoparticles could recapitulate cell adhesive behavior in re-
lation to the ﬁbronectin fragment and natural whole-length
counterpart 220 kDa.
D. Quantiﬁcation of FNf exposure from micropatterned
nanoparticles
Ligand adsorption of FNf and FNf-ANPs on untreated
and plasma-treated polyDTE-co-8% PEG1K carbonate was
conﬁrmed by ELISA Fig. 6. The lower nanoparticle adsorp-
tion on the untreated polymer is caused by the presence of
polyethylene glycol, or PEG, which inhibits protein, and
subsequently nanoparticle, adsorption. Plasma treatment,
however, increases the surface energy and negative charge
on the surface of the polymer. The higher surface energy of
polyDTE-co-8% PEG1K carbonate is indicated by the com-
pletely wetting contact angle upon plasma treatment, in com-
parison to the contact angle of the untreated polymer of
692°.
The ELISA data showed that plasma treatment of the
polymer induces greater levels of FNf exposure on FNf-
ANPs. These data likely indicate that differences in adsorp-
tion or binding of the FNf-ANPs on untreated and plasma-
treated surfaces induced differences in exposure of the
ligand. As a result, plasma-exposed stripes expose higher
ligand density than unexposed stripes, creating the cell pat-
terns in a selective way. With the more uniform substrate
coverage by the ligand alone, no cell patterning was induced.
E. Integrin mediated cell adhesion on micropatterned
nanoparticles
We examined MSC cell adhesion to patterned FNf-ANPs
in terms of the expression of the heterodimeric 5 and 1
integrin receptors to ﬁbronectin. Using immunolocalization
with two distinct antibodies against integrin 5 and 1
tagged secondarily with red and green ﬂuorophores, respec-
tively, we observed that cells adherent to micropatterned
FNf-ANPs express colocalization of multiple integrin 5 and
1. Several differences in the cell morphology were evident
at higher magniﬁcation. Cells on Fnf-ANPs showed more
polygonal core shape and multiple smaller extensions, end-
ing in knobbed lamellipodial ends, which were rich in colo-
calized integrins, whereas cells on FnF ligand control
showed more extensive membrane elongation and branching,
and the colocalized integrins, while visible throughout the
cell body, were not pronounced at the ends of cell processes
Fig. 7.
FIG. 5. Color Human mesenchymal stem cells adhere and organize effec-
tively on spatially patterned albumin nanoparticles. Fluorescent images
green—actin; blue—DAPI show MSCs patterned with FNf-functionalized
albumin nanoparticles A 4; B 20, compared to those patterned on
FNf fragment control C 4; D 20, and on positive control, whole-
length ﬁbronectin E 4; F 20. Patterning was sparse with ligand
alone. Patterning with the FNf-ANPs is more effective than with FNf alone,
yields more contiguous organization than whole-length ﬁbronectin control,
and cells clearly spread within the plasma-exposed stripes C and D.
FIG. 6. Gas plasma treatment induces selective ligand exposure of function-
alized albumin nanoparticles, but not for traditionally adsorbed ligand alone.
ELISA studies conﬁrm that the FNf-ANPs exhibit selective ligand pattern-
ing on plasma-treated polyDTE-co-8% PEG1K carbonate substrates, a fea-
ture that was exploited to use FNf-ANPs as carriers to display otherwise
nonselective ligand. The ligand FNf and FNf-ANPs at net equivalent
amounts of ligand were deposited on untreated polymer spin-coated glass
coverslips at approximately 1.53 m /cm2. No statistical difference in
ligand-alone adsorption was observed when comparing untreated polyDTE-
co-8% PEG1K carbonate and polyDTE-co-8% PEG1K carbonate plasma-
treated for 120 s, while plasma-treated polymer showed a signiﬁcant in-
crease in ligand exposure on FNf-ANPs.
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IV. DISCUSSION
We sought to develop a platform to pattern organic nano-
particles onto bioresorbable polymers, with the goal of pre-
senting biological cues for adhesion of cells. Our platform
restricts the deposition of organic ANPs within plasma-
treated regions on bioresorbable polymers that have limited
levels of biopermissivity. The spatial treatment, termed as
-PIP Ref. 35, utilizes oxygen gas plasma to temporarily
modify and functionalize the surface of materials.36 Func-
tionalization with oxygen gas plasma etches the polymer sur-
face and increases the surface energy of the substrate.37,38
Speciﬁcally, the ionized gas oxidizes the polymer surface
and induces the formation of –COO− and –CO3 functional
end groups that render hydrophobic polymers more
hydrophilic.35,39,40 PolyDTE-co-8% PEG1K carbonate was
selected as the basally nonbiopermissive polymer due to the
fact that it inhibits both protein and cell adsorption to the
surface.34,41 Treatment of selected regions of the polymer
with the oxygen plasma, however, increases the surface en-
ergy and hydrophilicity of the polymer, causing these regions
to become permissive substrates for proteins and protein-
based nanoparticles.
We examined the feasibility of establishing biological or-
ganization by using organic nanoparticles patterned on non-
permissive, biocompatible substrates. The functionalized
ANPs were previously shown to enhance the ability of hu-
man skin epithelial cells, called keratinocytes, to migrate27
and induce accelerated assembly of ﬁbronectin in the extra-
cellular matrix by human ﬁbroblasts,33 two processes crucial
to wound healing in the skin. In both studies, it was found
that cell response was enhanced by the presentation of the
FNf from albumin-derived nanoparticles in comparison to
presenting the FNf alone on the substrate. In this study, we
proposed to use the FNf-functionalized albumin nanopar-
ticles as the key model bionanoparticles for micropatterning
studies. By ﬂuorescence, atomic force, and scanning electron
microscopy, we found that adsorption of ANPs is greater on
plasma-exposed polymer in comparison to plasma-protected
polymer. ELISA measurements showed that FNf adsorption
was not statistically different in plasma-exposed and unex-
posed regions of the polymer, while ligand exposure on FNf-
ANP was signiﬁcantly enhanced in plasma-exposed regions
than unexposed regions. Separately, we probed the interac-
tions between the nanoparticle and the polymer substrate fol-
lowing plasma treatment of polyDTE-co-8% PEG1K car-
bonate. The zeta potential of the unfunctionalized
nanoparticles and functionalized nanoparticles were
−11.204.59 and −12.432.25, respectively, indicating
that their surface charge is only slightly negative in PBS, and
that ligand conjugation does not change the surface charge
properties signiﬁcantly. Using ﬂuorolabeled nanoparticles,
we found that the ﬂuorescent intensity RFI of the albumin
nanoparticles was 161355 on untreated polymer, com-
pared to 71817 on polymer pretreated with plasma for 120
s. The lower RFI value indicates a slightly lower amount of
negatively charged nanoparticles adsorbed on the plasma-
treated polyDTE-co-8% PEG1K carbonate. Therefore, we
postulate that the modest repulsive effects of increased nega-
tive surface charge of plasma polyDTE-co-8% PEG1K car-
bonate are outweighed by the increase in the surface energy
and functionalization of the surface, promoting adsorption of
the nanoparticles to the surface.
Patterning of the ANPs allowed for the spatial guidance of
human mesenchymal stem cells and ﬁbroblasts. Both cell
types were not only conﬁned to the plasma-exposed areas
upon attachment, forming clear patterns, but they also spread
within these regions; when patterning with the ligand alone,
patterns of both cell types appeared patchy, and cells did not
spread within the exposed areas. MSCs exhibited a distinct
morphology on ligand-functionalized ANPs, characterized
by polygonal core spreading and small peripheral extensions
with knobbed ends, in contrast to the more restricted core
spreading but longer extensions and branching on ligand
controls. The nanoparticle substrates supported cell adhesion
mediated by colocalized integrin 5 and 1, which showed
pronounced distribution in puncta at the ends of cell exten-
sions. We believe that these effects resulted from a combina-
tion of enhanced ligand exposure induced by plasma treat-
ment of ligand-speciﬁc integrin receptors, differences in
nanotopography of the substrates, and integrin remodeling
due to localized clustering. We have previously reported that
the nanoscale ANP-based presentation can modulate, as a
function of ANP nanoscale size, the cytoskeletal contractility
and integrin translocation, which implicates synergistic ef-
fects of nanotopography and integrin distribution dynamics
exerted by ligand presentation on albumin nanoparticles.33,42
Thus, spatially micropatterned ligand-functionalized nano-
FIG. 7. Color Human MSCs adherent to micropatterned FNf-ANPs show
distinct morphology and integrin 5 and 1 distribution visualized via im-
munolocalization and confocal microscopy. -PIP was used to spatially mi-
cropattern the functionalized nanoparticles A and B and the ligand
alone C and D. Immunocytochemistry images green—integrin 1;
red—integrin 5 were taken at 10 A and C and 63 B and D.
Note that cells patterned with FNf-ANPs dashed lines show more polygo-
nal shape with numerous smaller peripheral extension where pronounced
colocalization of integrin 5 and integrin 1 was observed the tips of
pseudopodia B. In contrast, cells on FNf controls showed restricted core
spreading but extensive longer membrane processes and limited integrin
colocalization at the pseudopodial tips C and D.
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particles could present effective tools to study and manipu-
late these processes in response to strategic ligands and vary-
ing nanoparticle features.
V. CONCLUSIONS
Patterning of cells is of interest for applications in tissue
engineering, sensors and bioMEMs devices, among others.
Conﬁning cells to simple and complex patterns can help pro-
vide clues on cellular processes such as attachment, migra-
tion, and differentiation,36 as well as cell-cell and cell-matrix
interactions. However, while patterning with some proteins,
such as ﬁbronectin and laminin, has been successful, pattern-
ing with smaller ligands derived from the whole-length ma-
trix proteins can be challenging and even unsuccessful, as
shown here with a truncated fragment of ﬁbronectin and
RGD peptide.
By conjugating ligands on biocompatible, albumin-
derived nanoparticles, it is possible to promote cell pattern-
ing using microscale plasma-initiated patterning. -PIP is a
simple technique that can be used on nonconductive sub-
strates for patterning of biodegradable, protein-based materi-
als. Unlike microcontact printing, which can be patchy and is
limited to materials of very speciﬁc surface chemistry, -PIP
is very efﬁcient for patterning a wider variety of materials.
While we speciﬁcally chose microscale features because
these range along the same size as cell processes, patterning
depends on the features of the PDMS stamps, which can be
tailored for nanoscale features. Aside from improving the
presentation of ligands that do not preferentially adsorb to
different substrates, patterning with nanoparticles could be
helpful for presentation of ligands and proteins that undergo
conformational changes due to interactions with the sub-
strate, allowing them to retain activity.
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